Literature DB >> 20733511

Dysfunctional cognitions, anxiety and depression in irritable bowel syndrome.

Annemieke Y Thijssen1, Dorothea M A E Jonkers, Carsten Leue, Patrick P J van der Veek, Michelle Vidakovic-Vukic, Yanda R van Rood, Cornelis H M Clemens, Ad A M Masclee.   

Abstract

GOALS AND
BACKGROUND: Patients with irritable bowel syndrome (IBS) have significantly impaired quality of life (QoL). We investigated the presence of dysfunctional cognitions, anxiety, and depression symptoms and their impact on daily symptoms and QoL in a large IBS cohort. STUDY: A total of 268 IBS patients (Rome II criteria, age 18 to 65 y) were included. Patients completed a 2-week daily symptom diary. The Short Form-36 was used to score QoL. The 31-items Cognitive Scale for Functional Bowel Disorders (CSFBD) and the Hospital Anxiety and Depression Scale (HADS) were used to analyze the psychological factors.
RESULTS: Possible anxiety and depression disorders were present in 30% and 22% of IBS patients, respectively. Patients with anxiety and depression had significantly higher mean symptom scores, impaired QoL, and higher CSFBD scores (P<0.01). Physical and mental QoL were both affected by depression (HADS-D) and dysfunctional cognitions (P<0.01). Only physical QoL, not mental QoL, was affected by referral type (hospital setting vs. community based; P<0.01). Only mental QoL was affected by anxiety (HADS-A) (P<0.01). Dysfunctional cognitions independently of anxiety and depression influenced QoL and IBS symptoms.
CONCLUSIONS: In this IBS cohort, dysfunctional cognitions independently influence physical and mental QoL and symptom severity. Presence of possible anxiety and depression disorders resulted in higher symptoms, lower QoL, and higher CSFBD scores. The results point toward an important role of psychological factors, especially dysfunctional cognitions on QoL and symptom scores in IBS patients.

Entities:  

Mesh:

Year:  2010        PMID: 20733511     DOI: 10.1097/MCG.0b013e3181eed5d8

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  29 in total

Review 1.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

Review 2.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

3.  Psychosocial characteristics and pain burden of patients with suspected sphincter of Oddi dysfunction in the EPISOD multicenter trial.

Authors:  Olga Brawman-Mintzer; Valerie Durkalski; Qi Wu; Joseph Romagnuolo; Evan Fogel; Paul Tarnasky; Giuseppe Aliperti; Martin Freeman; Richard Kozarek; Priya Jamidar; Mel Wilcox; Grace Elta; Kyle Orrell; April Wood; Patrick Mauldin; Jose Serrano; Douglas Drossman; Patricia Robuck; Peter Cotton
Journal:  Am J Gastroenterol       Date:  2014-01-21       Impact factor: 10.864

4.  Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization.

Authors:  Uri Ladabaum; Erin Boyd; Wei K Zhao; Ajitha Mannalithara; Annie Sharabidze; Gurkirpal Singh; Elaine Chung; Theodore R Levin
Journal:  Clin Gastroenterol Hepatol       Date:  2011-08-24       Impact factor: 11.382

Review 5.  Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model.

Authors:  Cristina Stasi; Massimo Rosselli; Massimo Bellini; Giacomo Laffi; Stefano Milani
Journal:  J Gastroenterol       Date:  2012-07-06       Impact factor: 7.527

6.  Depression and anxiety associated with functional bowel disorders and its impact on quality of life: A cross-sectional study.

Authors:  Sukanto Sarkar; Sunayana Choudhury; Sivaprakash Balasundaram; SajeethManikanda Prabu Balasubramanian
Journal:  Ind Psychiatry J       Date:  2020-11-07

7.  Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety.

Authors:  Ling Lan; Yu-Long Chen; Hao Zhang; Bai-Ling Jia; Yan-Jun Chu; Jin Wang; Shi-Xiao Tang; Guo-Dong Xia
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

8.  An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-D.

Authors:  Brian E Lacy; William D Chey; Lin Chang
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-11

Review 9.  Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings.

Authors:  Enrique Coss-Adame; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2014-04

Review 10.  Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis.

Authors:  Hannibal Person; Laurie Keefer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-12-14       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.